Takayuki Kishi Selected Research

17,18-epoxy-5,8,11,14-eicosatetraenoic acid

1/2018

The 17,18-epoxyeicosatetraenoic acid-G protein-coupled receptor 40 axis ameliorates contact hypersensitivity by inhibiting neutrophil mobility in mice and cynomolgus macaques.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takayuki Kishi Research Topics

Disease

13	Myositis (Idiopathic Inflammatory Myopathies) 01/2023 - 01/2017
8	Dermatomyositis (Dermatopolymyositis) 01/2023 - 01/2017
4	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2021 - 01/2019
4	Melanoma (Melanoma, Malignant) 01/2021 - 11/2016
3	Exanthema (Rash) 01/2023 - 03/2021
2	Neoplasms (Cancer) 01/2022 - 01/2021
2	Arthralgia (Joint Pain) 01/2021 - 01/2018
2	Arthritis (Polyarthritis) 01/2021 - 01/2018
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 09/2020 - 01/2018
2	Polymyositis 01/2019 - 01/2018
2	Inflammation (Inflammations) 01/2018 - 03/2010
2	Abdominal Pain (Pain, Abdominal) 01/2015 - 01/2010
2	Behcet Syndrome (Behcet's Syndrome) 01/2015 - 01/2010
1	Calcinosis 01/2022
1	Erythema 03/2021
1	Lymphadenopathy 01/2021
1	Contracture 01/2021
1	Rhabdomyosarcoma 01/2021
1	Starvation 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Dysphonia (Spastic Dysphonia) 01/2021
1	Pain (Aches) 09/2020
1	Hydrarthrosis 03/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2019
1	Muscle Weakness 01/2018
1	Synovitis 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Contact Dermatitis (Eczema, Contact) 01/2018
1	Cryopyrin-Associated Periodic Syndromes 03/2010
1	Joint Diseases (Joint Disease) 03/2010
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2010
1	Diarrhea 01/2010
1	Fibrosis (Cirrhosis) 06/2009
1	Infantile Spasms (West Syndrome) 01/2006

Drug/Important Bio-Agent (IBA)

13	AutoantibodiesIBA 01/2023 - 01/2017
4	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2021 - 06/2009
2	SS-A antibodiesIBA 01/2023 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 04/2022 - 11/2016
2	nuclear matrix protein 2IBA 01/2022 - 01/2021
2	transcriptional intermediary factor 1IBA 01/2021 - 11/2018
2	Adalimumab (Humira)FDA Link 01/2018 - 01/2015
1	AntibodiesIBA 10/2021
1	SteroidsIBA 03/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	LigandsIBA 01/2021
1	NADP (NADPH)IBA 01/2021
1	amsonic acid (DAS)IBA 09/2020
1	Anti-Citrullinated Protein AntibodiesIBA 03/2020
1	Ligases (Synthetase)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2019
1	EnzymesIBA 01/2018
1	17,18-epoxy-5,8,11,14-eicosatetraenoic acidIBA 01/2018
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2018
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2018
1	Eicosapentaenoic AcidIBA 01/2018
1	5'-Nucleotidase (5' Nucleotidase)IBA 01/2018
1	LipidsIBA 01/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2018
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Oxidoreductases (Dehydrogenase)IBA 01/2017
1	Methylprednisolone FDA LinkGeneric 01/2015
1	Interleukin-1 (Interleukin 1)IBA 03/2010
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 03/2010
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 03/2010
1	dimemorfan (AT 17)IBA 01/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010
1	Infliximab (Remicade)FDA Link 01/2010
1	Immunosuppressive Agents (Immunosuppressants)IBA 06/2009
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2006
1	Therapeutic UsesIBA 01/2006

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2010
1	Aftercare (After-Treatment) 03/2021